These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1825534)

  • 21. Elevated urinary excretion of thromboxane B2 in adults with minimal-change nephrotic syndrome.
    Matsumoto H; Nakao T
    Clin Nephrol; 2000 Jan; 53(1):75-6. PubMed ID: 10661487
    [No Abstract]   [Full Text] [Related]  

  • 22. [Measurement of urinary TXB2, 6-keto-PGF1 alpha by radioimmunoassay and its clinical significance].
    Dong DC; Zhong L
    Zhonghua Nei Ke Za Zhi; 1987 Dec; 26(12):704-6, 743. PubMed ID: 3451855
    [No Abstract]   [Full Text] [Related]  

  • 23. Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion.
    Kangasaho M; Hillbom M; Kaste M; Wuorela H; Vapaatalo H
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():223-8. PubMed ID: 6303086
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of dehydrocorydaline on formation of thromboxane B2 in platelets and 6-keto-pgf1 alpha in rabbit aorta].
    Yang J; Wang YM; Chai RH
    Yao Xue Xue Bao; 1989; 24(6):472-5. PubMed ID: 2609987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs.
    McLewee N; Archer T; Wills R; Mackin A; Thomason J
    J Vet Pharmacol Ther; 2018 Feb; 41(1):60-67. PubMed ID: 28664658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet function during acetaldehyde intoxication in healthy male volunteers.
    Neiman J; Hillbom M; Jones AW; Benthin G; Löwbeer C
    Alcohol Alcohol Suppl; 1987; 1():587-90. PubMed ID: 3426736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction.
    Delemarre FM; Thomas CM; van den Berg RJ; Jongsma HW; Steegers EA
    Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):209-15. PubMed ID: 11049696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary thromboxane and 6-keto-prostaglandin F1 alpha are early markers of acute rejection in experimental pancreas transplantation.
    Johnson BF; Wiley KN; Greaves M; Preston FE; Fox M; Raftery AT
    Transplantation; 1994 Jul; 58(1):18-23. PubMed ID: 7518618
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of dl-3-n-butylphthalide on production of TXB2 and 6-keto-PGF1 alpha in rat brain during focal cerebral ischemia and reperfusion.
    Chong ZZ; Feng YP
    Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):505-8. PubMed ID: 10322905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of vasoactive substances in chronic renal failure.
    Cantaro S; Milan Manani S; Marcon R; Bonfante L; Masiero M; D'Angelo A; Calò L
    Clin Nephrol; 2001 May; 55(5):393-9. PubMed ID: 11393385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of 6-keto-prostaglandin F1 alpha and thromboxane B2 in urine by high-performance liquid chromatography and radioimmunoassay.
    Wilson TW; McCauley FA; Tuchek JM
    J Chromatogr; 1984 Mar; 306():351-7. PubMed ID: 6546935
    [No Abstract]   [Full Text] [Related]  

  • 34. Slow-release aspirin and prostaglandin inhibition.
    Roberts MS; Joyce RM; McLeod LJ; Vial JH; Seville PR
    Lancet; 1986 May; 1(8490):1153-4. PubMed ID: 2871403
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs.
    Vesterqvist O; Gréen K
    Prostaglandins; 1984 Jul; 28(1):139-54. PubMed ID: 6548317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary thromboxane B2 on allograft rejection.
    Mahoney DA; Barden AE; Vandongen R; Hurst P; Banks R; Beilin LJ; Saker B; Thatcher G
    Lancet; 1981 Nov; 2(8254):1046. PubMed ID: 6118500
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of aspirin on urinary excretion of 6-ketoprostaglandin F1 alpha.
    Jones PB; Russell RG
    Clin Sci (Lond); 1983 Apr; 64(4):395-8. PubMed ID: 6687451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of rat cardiac allograft survival with arachidonic acid metabolism inhibitor.
    Kagawa K; Kasahara K; Sakurai Y; Omoto K; Masuda A; Nonoyama A; Kagawa T
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1308-11. PubMed ID: 3103286
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin resistance: definition, mechanisms and clinical read-outs.
    Patrono C
    J Thromb Haemost; 2003 Aug; 1(8):1710-3. PubMed ID: 12911581
    [No Abstract]   [Full Text] [Related]  

  • 40. Bladder contributes to eicosanoids excreted in urine.
    Reyes AA; Klahr S
    Am J Physiol; 1990 Nov; 259(5 Pt 2):F859-61. PubMed ID: 2240235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.